{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:39:03Z","timestamp":1783226343195,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jcyt.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T23:59:20Z","timestamp":1647820760000},"page":"473-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cryopreserved hematopoietic stem\/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project team"],"prefix":"10.1016","volume":"24","author":[{"given":"Ronit","family":"Reich-Slotky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana V.","family":"Vasovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Halpenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Woeltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aby J.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Stasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcyt.2022.03.001_bib0001","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/bmt.2013.176","article-title":"Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates","volume":"49","author":"Hahn","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2022.03.001_bib0002","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/trf.12006","article-title":"Avoiding room temperature storage and delayed cryopreservation provide better postthaw potency in hematopoietic progenitor cell grafts","volume":"53","author":"Fry","year":"2013","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.jcyt.2022.03.001_bib0003","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jcyt.2014.02.005","article-title":"Long-term effects of cryopreservation on clinically prepared hematopoietic progenitor cell products","volume":"16","author":"Winter","year":"2014","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2022.03.001_bib0004","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jca.21914","article-title":"Race\/ethnicity and underlying disease influences hematopoietic stem\/progenitor cell mobilization response: a single center experience","volume":"36","author":"Uzoka","year":"2021","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0005","series-title":"Title 21 CFR Part 1271","year":"2020"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0006","series-title":"Title 21 CFR Part 210","article-title":"Current good manufacturing practice in manufcturing, processing, packing, or holding of drugs","year":"2020"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0007","series-title":"Title 21 CFR Part 211","article-title":"Current good manufacturing practice for finished pharmaceuticals","year":"2020"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0008","unstructured":"Code of federal regulation. General biological product standards. title 21 CFR Part 610. In. Washington, DC: US Government Printing Office; 2020 (revised annually)."},{"key":"10.1016\/j.jcyt.2022.03.001_bib0009","series-title":"FACT-JACIE international standards for cellular therapy product collection, processing. And administration","year":"2021"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0010","series-title":"Standards for cellular therapy services","year":"2021"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0011","series-title":"Q1A(R2) Stability Testing of New Drug Substances and Products","year":"2009"},{"issue":"18","key":"10.1016\/j.jcyt.2022.03.001_bib0012","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1182\/blood-2011-01-330514","article-title":"Hematopoietic stem\/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood","volume":"117","author":"Broxmeyer","year":"2011","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2022.03.001_bib0013","first-page":"45","article-title":"High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10\u2009years","volume":"107","author":"Broxmeyer","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.jcyt.2022.03.001_bib0014","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ajh.20707","article-title":"Cryopreservation of hematopoietic stem cells","volume":"82","author":"Berz","year":"2007","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.jcyt.2022.03.001_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","article-title":"The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering","volume":"5","author":"Sutherland","year":"1996","journal-title":"J Hematother"},{"issue":"2","key":"10.1016\/j.jcyt.2022.03.001_bib0016","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO;2-F","article-title":"Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering","volume":"34","author":"Keeney","year":"1998","journal-title":"Cytometry"},{"issue":"9","key":"10.1016\/j.jcyt.2022.03.001_bib0017","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1016\/j.transproceed.2009.06.191","article-title":"Factors affecting neutrophil recovery after autologous bone marrow-derived stem cell transplantation in patients with acute myeloid leukemia","volume":"41","author":"Kozlowska-Skrzypczak","year":"2009","journal-title":"Transplant Proc"},{"issue":"43","key":"10.1016\/j.jcyt.2022.03.001_bib0018","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1038\/sj.onc.1207941","article-title":"Identification of hematopoietic stem\/progenitor cells: strength and drawbacks of functional assays","volume":"23","author":"Coulombel","year":"2004","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.jcyt.2022.03.001_bib0019","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcyt.2012.11.013","article-title":"Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the biomedical excellence for safer transfusion (BEST) collaborative","volume":"15","author":"Pamphilon","year":"2013","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.jcyt.2022.03.001_bib0020","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/j.1537-2995.2012.03650.x","article-title":"Impact of storage temperature and processing delays on cord blood quality: discrepancy between functional in vitro and in vivo assays","volume":"52","author":"Louis","year":"2012","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.jcyt.2022.03.001_bib0021","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488808786734006","article-title":"Aldehyde dehydrogenase as a marker for stem cells","volume":"3","author":"Moreb","year":"2008","journal-title":"Curr Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.jcyt.2022.03.001_bib0022","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0011-2240(89)90016-3","article-title":"Viability assays for preserved cells, tissues, and organs","volume":"26","author":"Pegg","year":"1989","journal-title":"Cryobiology"},{"issue":"3","key":"10.1016\/j.jcyt.2022.03.001_bib0023","first-page":"203","article-title":"Processing and storage of human bone marrow: a survey of current practices in North America","volume":"6","author":"Areman","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0024","first-page":"523","article-title":"Cryopreservation and storage of human bone marrow: a survey of current practices","volume":"333","author":"Areman","year":"1990","journal-title":"Prog Clin Biol Res"},{"issue":"3","key":"10.1016\/j.jcyt.2022.03.001_bib0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1700644","article-title":"The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells","volume":"19","author":"Katayama","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2022.03.001_bib0026","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00277-014-2112-2","article-title":"Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single Centre","volume":"93","author":"Bai","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0027","series-title":"Banking, and release for Administartion","year":"2019"},{"issue":"1\u20132","key":"10.1016\/j.jcyt.2022.03.001_bib0028","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-1759(00)00232-5","article-title":"Detection of dead cells and measurement of cell killing by flow cytometry","volume":"243","author":"King","year":"2000","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.jcyt.2022.03.001_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2008.150","article-title":"Classification of cell death: recommendations of the nomenclature committee on cell death 2009","volume":"16","author":"Kroemer","year":"2009","journal-title":"Cell Death Differ"},{"issue":"3","key":"10.1016\/j.jcyt.2022.03.001_bib0030","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1537-2995.2011.03305.x","article-title":"Flow cytometry assessment of apoptotic CD34+ cells by annexin V labeling may improve prediction of cord blood potency for engraftment","volume":"52","author":"Duggleby","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/823912","article-title":"The assessment of parameters affecting the quality of cord blood by the appliance of the Annexin V staining method and correlation with CFU assays","volume":"2013","author":"Radke","year":"2013","journal-title":"Stem Cells Int"},{"issue":"4","key":"10.1016\/j.jcyt.2022.03.001_bib0032","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1423-0410.2007.001028.x","article-title":"Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity","volume":"94","author":"Reich-Slotky","year":"2008","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.jcyt.2022.03.001_bib0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcyt.2019.10.009","article-title":"Multi-laboratory assay for harmonization of enumeration of viable CD34+ and CD45+ cells in frozen cord blood units","volume":"22","author":"Fournier","year":"2020","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1016\/j.jcyt.2022.03.001_bib0034","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.bmt.1704247","article-title":"Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation","volume":"32","author":"Yang","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2022.03.001_bib0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1423-0410.2007.01009.x","article-title":"Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation","volume":"94","author":"Lee","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.jcyt.2022.03.001_bib0036","doi-asserted-by":"crossref","unstructured":"Mahmud N. Cryopreservation of stem cell product. In: Chandy M, Radhakrishnan VS, Sukumaran R. (eds), Contemporary Bone Marrow Transplantation. Organ and Tissue Transplantation. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-64938-2_16-1","DOI":"10.1007\/978-3-319-64938-2_16-1"},{"issue":"Supplement_1","key":"10.1016\/j.jcyt.2022.03.001_bib0037","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2019-132145","article-title":"Nadim Mahmud. Monitoring of stored hematopoietic stem\/progenitor graft stability program in a single institute","volume":"134","author":"Park","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jcyt.2022.03.001_bib0038","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/trf.14777","article-title":"Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the biomedical excellence for safer transfusion (BEST) collaborative","volume":"58","author":"Takanashi","year":"2018","journal-title":"Transfusion"},{"issue":"11\u201312","key":"10.1016\/j.jcyt.2022.03.001_bib0039","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1537-2995.1996.36111297091743.x","article-title":"Evaluation of methods for preparing and thawing cryopreserved CD34+ and CD34- cell lines for use as reagents in flow cytometry of hematopoietic progenitor cells","volume":"36","author":"Bowman","year":"1996","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.jcyt.2022.03.001_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/152581600319379","article-title":"Osmometric and permeability characteristics of human placental\/umbilical cord blood CD34+ cells and their application to cryopreservation","volume":"9","author":"Woods","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"issue":"12","key":"10.1016\/j.jcyt.2022.03.001_bib0041","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bmt.1703575","article-title":"Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation","volume":"29","author":"Allan","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2022.03.001_bib0042","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2257.1999.00253.x","article-title":"Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology task force of the British Committee for Standards in Haematology","volume":"21","author":"Barnett","year":"1999","journal-title":"Clin Lab Haematol"},{"issue":"6","key":"10.1016\/j.jcyt.2022.03.001_bib0043","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/trf.15220","article-title":"An objective flow cytometry method to rapidly determine cord blood potency in cryopreserved units","volume":"59","author":"Simard","year":"2019","journal-title":"Transfusion"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:47:36Z","timestamp":1761443256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324922000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1465324922000706"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.03.001","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryopreserved hematopoietic stem\/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project team","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of International Society for Cell &#38; Gene Therapy.","name":"copyright","label":"Copyright"}]}}